Role of T-bet in Commitment of T H 1 Cells Before IL-12-Dependent Selection
- 8 June 2001
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 292 (5523), 1907-1910
- https://doi.org/10.1126/science.1059835
Abstract
How cytokines control differentiation of helper T (TH) cells is controversial. We show that T-bet, without apparent assistance from interleukin 12 (IL-12)/STAT4, specifies TH1 effector fate by targeting chromatin remodeling to individual interferon-γ (IFN-γ) alleles and by inducing IL-12 receptor β2 expression. Subsequently, it appears that IL-12/STAT4 serves two essential functions in the development of TH1 cells: as growth signal, inducing survival and cell division; and as trans-activator, prolonging IFN-γ synthesis through a genetic interaction with the coactivator, CREB-binding protein. These results suggest that a cytokine does not simply induce THfate choice but instead may act as an essential secondary stimulus that mediates selective survival of a lineage.Keywords
This publication has 27 references indexed in Scilit:
- Cloning and Characterization of a New Member of the T-Box Gene FamilyGenomics, 2000
- Signaling and Transcription in T Helper DevelopmentAnnual Review of Immunology, 2000
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999
- Instruction, Selection, or Tampering with the Odds?Science, 1999
- Independent and Epigenetic Regulation of the Interleukin-4 Alleles in CD4 + T CellsScience, 1998
- Monoallelic Expression of the Interleukin-2 LocusScience, 1998
- Transcription Factor-Specific Requirements for Coactivators and Their Acetyltransferase FunctionsScience, 1998
- Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient miceNature, 1996
- Stat6 Is Required for Mediating Responses to IL-4 and for the Development of Th2 CellsImmunity, 1996
- The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice.The Journal of Experimental Medicine, 1992